The results showed that high HOTAIR expression was associated with an advanced clinical tumor stage (OR = 3.90, 95% CI = 3.02–5.03, P < .001), lymph node metastasis (OR = 3.11, 95% CI = 2.15–4.49, P < .001), poor differentiation of the tumor (OR = 1.56, 95% CI = 1.01–2.41, P = .03), and worse prognosis (HR = 2.16, 95% CI = 1.73–2.69, P < .001) in different cancer types. Here, HOTAIR is linked to cancer.